Clinical trial reports

  • Which Endpoints Are Measured Most Often in European Phase II & III Diabetes Mellitus Trials?
  • Which Endpoints Are Measured Most Often in European Bladder and Urothelial Cancer Phase II & III Trials?
  • Which endpoints are most frequently measured in European Phase II and III glioblastoma and glioma clinical trials?
  • Which Endpoints Are Measured Most Often in European Alzheimer’s and Dementia Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Lupus Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Psoriasis and Psoriatic Arthritis Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Myelodysplastic Syndrome Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Phase II & III Depression and Major Depressive Disorder Trials?
  • Which Endpoints Are Most Frequently Measured in European Chronic Kidney Disease and Kidney Failure Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Phase II & III Renal Cell Carcinoma Trials?
  • Which Endpoints Are Measured Most Often in European HCC Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Heart Failure Phase II & III Trials?